Bristol-Myers Squibb Company (BVL:BMY)
Peru · Delayed Price · Currency is PEN · Price in USD 53.06
0.00 (0.00%)
At close: Feb 18, 2026
BVL:BMY Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7,054 | -8,948 | 8,025 | 6,327 | 6,994 |
Depreciation & Amortization | 4,077 | 9,575 | 9,769 | 10,282 | 10,757 |
Loss (Gain) From Sale of Assets | -36 | -15 | -22 | -231 | -18 |
Asset Writedown & Restructuring Costs | 4,863 | 16,412 | 1,210 | 999 | 2,368 |
Loss (Gain) From Sale of Investments | -280 | -16 | 160 | 801 | -745 |
Stock-Based Compensation | 553 | 507 | 518 | 457 | 583 |
Other Operating Activities | -1,620 | -3,135 | -3,886 | -3,340 | -2,471 |
Change in Accounts Receivable | -295 | 264 | -995 | -663 | -1,054 |
Change in Inventory | -184 | -486 | -751 | -69 | 13 |
Change in Accounts Payable | -2 | 184 | 198 | 109 | 245 |
Change in Income Taxes | -4 | -1,260 | -603 | -1,423 | -1,063 |
Change in Other Net Operating Assets | 30 | 2,108 | 237 | -183 | 598 |
Operating Cash Flow | 14,156 | 15,190 | 13,860 | 13,066 | 16,207 |
Operating Cash Flow Growth | -6.81% | 9.60% | 6.08% | -19.38% | 15.34% |
Capital Expenditures | -1,311 | -1,248 | -1,209 | -1,118 | -973 |
Cash Acquisitions | -3,944 | -21,821 | -1,169 | -4,286 | -1,610 |
Divestitures | 1,071 | 1,099 | 909 | 1,305 | 748 |
Investment in Securities | 52 | 618 | -826 | 3,037 | 1,297 |
Investing Cash Flow | -4,132 | -21,352 | -2,295 | -1,062 | -538 |
Short-Term Debt Issued | 25 | 3,086 | - | 194 | - |
Long-Term Debt Issued | 5,740 | 12,883 | 4,455 | 5,926 | - |
Total Debt Issued | 5,765 | 15,969 | 4,455 | 6,120 | - |
Short-Term Debt Repaid | - | -3,000 | -120 | - | -160 |
Long-Term Debt Repaid | -10,940 | -2,873 | -3,879 | -11,431 | -6,022 |
Total Debt Repaid | -10,940 | -5,873 | -3,999 | -11,431 | -6,182 |
Net Debt Issued (Repaid) | -5,175 | 10,096 | 456 | -5,311 | -6,182 |
Issuance of Common Stock | - | - | 27 | 984 | - |
Repurchase of Common Stock | - | - | -5,155 | -8,001 | -6,287 |
Common Dividends Paid | -5,045 | -4,863 | -4,744 | -4,634 | -4,396 |
Other Financing Activities | -128 | -106 | - | - | 641 |
Financing Cash Flow | -10,348 | 5,127 | -9,416 | -16,962 | -16,224 |
Foreign Exchange Rate Adjustments | 195 | -137 | 45 | -33 | -102 |
Net Cash Flow | -129 | -1,172 | 2,194 | -4,991 | -657 |
Free Cash Flow | 12,845 | 13,942 | 12,651 | 11,948 | 15,234 |
Free Cash Flow Growth | -7.87% | 10.21% | 5.88% | -21.57% | 14.55% |
Free Cash Flow Margin | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% |
Free Cash Flow Per Share | 6.30 | 6.88 | 6.09 | 5.57 | 6.79 |
Cash Interest Paid | 2,100 | 1,800 | 1,200 | 1,400 | 1,500 |
Cash Income Tax Paid | 3,264 | 3,900 | 4,300 | 5,400 | 3,500 |
Levered Free Cash Flow | 11,147 | 16,890 | 13,602 | 13,341 | 12,786 |
Unlevered Free Cash Flow | 12,329 | 18,114 | 14,327 | 14,094 | 13,601 |
Change in Working Capital | -455 | 810 | -1,914 | -2,229 | -1,261 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.